Homology Medicines Inc (DELISTED) (FIXX:DL)
0.9347
-15.76
(-94.40%)
USD |
NASDAQ |
Mar 25, 16:00
Homology Medicines Revenue (Annual): 1.156M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 1.156M |
December 31, 2022 | 3.208M |
December 31, 2021 | 33.97M |
Date | Value |
---|---|
December 31, 2020 | 2.702M |
December 31, 2019 | 1.666M |
December 31, 2018 | 5.322M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.156M
Minimum
2023
33.97M
Maximum
2021
8.541M
Average
2.702M
Median
2020
Revenue (Annual) Benchmarks
Societal CDMO Inc (DELISTED) | 94.64M |
AgeX Therapeutics Inc (DELISTED) | 0.034M |
NovaBay Pharmaceuticals Inc | 14.73M |
Palatin Technologies Inc | 4.854M |
iBio Inc | 0.225M |